Literature DB >> 20508226

Continuous subcutaneous insulin infusion is better than multiple daily insulin injections in reducing glucose variability only in type 1 diabetes with good metabolic control.

Giuseppe Lepore, Anna Corsi, Alessandro R Dodesini, Italo Nosari, Roberto Trevisan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20508226     DOI： 10.2337/dc10-0355

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  3 in total

1.  Continuous subcutaneous insulin infusion-an opportunity for better care but not a "magic pill".

Authors:  Avivit Cahn; Eytan Roitman; Genya Aharon-Hananel; Itamar Raz
Journal:  Endocrine       Date:  2016-12-30       Impact factor: 3.633

2.  The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study.

Authors:  Ignacio Conget; Javier Castaneda; Goran Petrovski; Bruno Guerci; Anne-Sophie Racault; Yves Reznik; Ohad Cohen; Sarah Runzis; Simona de Portu; Ronnie Aronson
Journal:  Diabetes Technol Ther       Date:  2015-08-04       Impact factor: 6.118

3.  HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment.

Authors:  Emma S Scott; Rachel T McGrath; Andrzej S Januszewski; Daniel Calandro; Anandwardhan A Hardikar; David N O'Neal; Gregory Fulcher; Alicia J Jenkins
Journal:  BMJ Open       Date:  2019-12-29       Impact factor: 2.692
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.